Artikel dengan mandat akses publik - Lorenzo LeggioPelajari lebih lanjut
Tidak tersedia di mana pun: 25
Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder
M Farokhnia, ML Faulkner, D Piacentino, MR Lee, L Leggio
Physiology & behavior 204, 49-57, 2019
Mandat: US National Institutes of Health
The gut in the brain: the effects of bariatric surgery on alcohol consumption
AN Blackburn, A Hajnal, L Leggio
Addiction biology 22 (6), 1540-1553, 2017
Mandat: US National Institutes of Health
Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis
C Pisanu, F Franconi, GL Gessa, S Mameli, GM Pisanu, I Campesi, ...
Pharmacological research 148, 104447, 2019
Mandat: US National Institutes of Health
Alcohol drinking patterns in young people: a survey-based study
G Martinotti, M Lupi, L Carlucci, R Santacroce, E Cinosi, T Acciavatti, ...
Journal of health psychology 22 (14), 1889-1896, 2017
Mandat: US National Institutes of Health
Oxytocin receptor mRNA expression in dorsolateral prefrontal cortex in major psychiatric disorders: a human post-mortem study
MR Lee, MB Sheskier, M Farokhnia, N Feng, S Marenco, BK Lipska, ...
Psychoneuroendocrinology 96, 143-147, 2018
Mandat: US National Institutes of Health
Understanding and treating patients with alcoholic cirrhosis: an update
G Addolorato, M Russell, E Albano, PS Haber, JR Wands, L Leggio
Alcoholism: Clinical and Experimental Research 33 (7), 1136-1144, 2009
Mandat: US National Institutes of Health
Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms
DJ Rohsenow, JW Tidey, RA Martin, SM Colby, RM Swift, L Leggio, ...
Addiction 112 (10), 1808-1820, 2017
Mandat: US National Institutes of Health, US Department of Veterans Affairs
Medication development for alcohol use disorder: a focus on clinical studies
L Leggio, DE Falk, ML Ryan, J Fertig, RZ Litten
Substance Use Disorders: From Etiology to Treatment, 443-462, 2020
Mandat: US National Institutes of Health
N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research
KC Morley, A Baillie, W Van Den Brink, KE Chitty, K Brady, SE Back, ...
Expert opinion on investigational drugs 27 (8), 667-675, 2018
Mandat: National Health and Medical Research Council, Australia
New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies
KC Morley, CJ Perry, J Watt, T Hurzeler, L Leggio, AJ Lawrence, P Haber
Expert Opinion on Pharmacotherapy 22 (10), 1291-1303, 2021
Mandat: US National Institutes of Health, National Health and Medical Research …
Relationship between craving and plasma leptin concentrations in patients with cocaine addiction
G Martinotti, C Montemitro, G Baroni, S Andreoli, F Alimonti, M Di Nicola, ...
Psychoneuroendocrinology 85, 35-41, 2017
Mandat: US National Institutes of Health
Simultaneous management of alcohol use disorder and liver disease: A systematic review and meta-analysis
MA Elfeki, MA Abdallah, L Leggio, AK Singal
Journal of Addiction Medicine 17 (2), e119-e128, 2023
Mandat: US National Institutes of Health
The influence of anxiety symptoms on clinical outcomes during baclofen treatment of alcohol use disorder: a systematic review and meta-analysis
R Agabio, DS Baldwin, H Amaro, L Leggio, JMA Sinclair
Neuroscience & Biobehavioral Reviews 125, 296-313, 2021
Mandat: US National Institutes of Health
Pharmacological manipulation of the ghrelin system and alcohol hangover symptoms in heavy drinking individuals: Is there a link?
M Farokhnia, MR Lee, LA Farinelli, VA Ramchandani, F Akhlaghi, ...
Pharmacology Biochemistry and Behavior 172, 39-49, 2018
Mandat: US National Institutes of Health
Investigational therapies for the pharmacological treatment of alcoholism
T Hillemacher, L Leggio, A Heberlein
Expert opinion on investigational drugs 24 (1), 17-30, 2015
Mandat: US National Institutes of Health
Combined pharmacotherapies for the management of alcoholism: rationale and evidence to date
MR Lee, L Leggio
CNS drugs 28, 107-119, 2014
Mandat: US National Institutes of Health
The glucagon‐like peptide‐1 system is modulated by acute and chronic alcohol exposure: Findings from human laboratory experiments and a post‐mortem brain study
M Farokhnia, BD Browning, ME Crozier, H Sun, F Akhlaghi, L Leggio
Addiction Biology 27 (5), e13211, 2022
Mandat: US National Institutes of Health
Effect of oral alcohol administration on plasma cytokine concentrations in heavy drinking individuals
MR Lee, KM Abshire, M Farokhnia, F Akhlaghi, L Leggio
Drug and alcohol dependence 225, 108771, 2021
Mandat: US National Institutes of Health
Thiamine administration to all patients with alcohol use disorder: why not?
R Agabio, L Leggio
The American Journal of Drug and Alcohol Abuse 47 (6), 651-654, 2021
Mandat: US National Institutes of Health
Changes in plasma ghrelin levels following surgical and non-surgical weight-loss in female rats predict alcohol use
E Orellana, N Horvath, M Farokhnia, L Leggio, A Hajnal
Brain Research Bulletin 188, 179-186, 2022
Mandat: US National Institutes of Health
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer